Insights On CONTRACT PHARMA MANUFACTURING
-
Mobilizing Science, Partnership, And Capability To Develop A Gene Therapy In 14 Months
9/17/2025
Hear how one family, driven by urgency, partnered with AAV experts to develop a treatment for their daughter’s ultra-rare neurodegenerative disorder, NEDAMSS, in just 14 months.
-
AbZelectPRO™: Enhanced Cell Line Development Platform
9/17/2025
Leveraging Abzena’s deep expertise in biologics development and supported by our comprehensive analytics suite, AbZelectPRO™ streamlines the IND application pathway, ensuring smooth progression into clinical phases.
-
Seizing The Opportunity Under EMA's Streamlined Guidelines
9/17/2025
Take proactive steps now to reduce development costs, accelerate approval, and unlock new opportunities in the shifting biosimilar landscape.
-
Fill-Finish Contract Manufacturing: Trends, Challenges, And The Future
9/16/2025
See why it's important to partner with a CDMO that’s investing in advanced sterile fill-finish capabilities to meet the demands of complex biologics, gene therapies, and mRNA-based products.
-
Nitrosamine Testing: How To Ensure Regulatory Compliance, Product Safety
9/16/2025
Explore what nitrosamines are, why testing matters, and how we're able to deliver high-confidence solutions through advanced science and industry-leading expertise.
-
AI For Faster, Smarter Gene Therapy Development And Manufacturing
9/15/2025
Here, we highlight real-world applications of AI in gene therapy, providing case studies and addressing the challenges and prerequisites for successful implementation.
-
CDMO Hunger Games And The State Of Biotech With Siren Biotechnology's Nicole Paulk, Ph.D.
9/9/2025
Biotech leader Nicole Paulk, Ph.D., joins “Better Biopharma” to discuss Siren Biotechnology’s switch from plasmids to producer cell lines, CGT funding challenges, and the competition that determined which CDMO won Siren’s business.
-
Protecting The Foundation Of Biologics With Flexible, Scalable Cell Banking
9/9/2025
Safeguard your cell banks with secure, compliant storage and streamlined delivery solutions that keep manufacturing on schedule and therapies moving forward.
-
ATMP Development In 2025: Promise, Pressure, And The Push To Scale
9/9/2025
Drive the next wave of cell and gene therapy innovation by overcoming operational, funding, and regulatory challenges to deliver life-changing treatments to patients faster.
-
Built For Speed: How To Deliver Without Compromise
9/9/2025
Ensure fast, reliable, temperature-controlled logistics with a global infrastructure designed to protect critical biologic materials and keep development programs running smoothly and on schedule.